Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A01283 | 34803490 | Int J Biol Sci | SOCS2 Suppresses Inflammation and Apoptosis during NASH Progression through Limiting NF-κB Activation in Macrophages. | 2021 | Details |
| A01284 | 34803389 | Clin Exp Gastroenterol | Activation and Functional Priming of Blood Neutrophils in Non-Alcoholic Fatty Liver Disease Increases in Non-Alcoholic Steatohepatitis. | 2021 | Details |
| A01285 | 34803123 | Endocr J | Prediction and validation of nonalcoholic fatty liver disease by fatty liver index in a Japanese population. | 2021 | Details |
| A01286 | 34802660 | Clin Liver Dis | Endoscopic Bariatric Interventions in Patients with Chronic Liver Disease. | 2021 | Details |
| A01288 | 34801522 | Biochem Pharmacol | Models of nonalcoholic steatohepatitis potentiated by chemical inducers leading to hepatocellular carcinoma. | 2021 | Details |
| A01291 | 34800721 | Ann Hepatol | Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C. | 2021 | Details |
| A01292 | 34799510 | Curr Opin Infect Dis | Frailty in people living with HIV: an update. | 2022 | Details |
| A01293 | 34799486 | Curr Opin Lipidol | Fatty liver and cerebrovascular disease: plausible association and possible mechanisms. | 2022 | Details |
| A01294 | 34798892 | BMC Complement Med Ther | Effect of cranberry supplementation on liver enzymes and cardiometabolic risk factors in patients with NAFLD: a randomized clinical trial. | 2021 | Details |
| A01295 | 34798835 | BMC Gastroenterol | PNPLA3 genotype and fibrosis-4 index predict cardiovascular diseases of Japanese patients with histopathologically-confirmed NAFLD. | 2021 | Details |
| A01296 | 34798335 | Clin Gastroenterol Hepatol | Metabolic Dysfunction-Associated Fatty Liver Disease and Subsequent Development of Adverse Pregnancy Outcomes. | 2021 | Details |
| A01297 | 34798176 | J Hepatol | MRI-based (MAST) score accurately identifies patients with NASH and significant fibrosis. | 2021 | Details |
| A01298 | 34798124 | Biochem Pharmacol | CYP4V2 fatty acid omega hydroxylase, a druggable target for the treatment of metabolic associated fatty liver disease (MAFLD). | 2021 | Details |
| A01299 | 34797530 | Rheumatol Ther | Psoriatic Arthritis: The Influence of Co-morbidities on Drug Choice. | 2021 | Details |
| A01300 | 34796193 | Front Nutr | Translatomics Probes Into the Role of Lycopene on Improving Hepatic Steatosis Induced by High-Fat Diet. | 2021 | Details |
| A01301 | 34796096 | Pediatr Gastroenterol Hepatol Nutr | Distinctive Features of Hepatic Steatosis in Children: Is It Primary or Secondary to Inborn Errors of Metabolism? | 2021 | Details |
| A01302 | 34795655 | Front Microbiol | Gut Microbiome-Mediated Alteration of Immunity, Inflammation, and Metabolism Involved in the Regulation of Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A01303 | 34795650 | Front Microbiol | Dextran Sulfate Sodium Salt-Induced Colitis Aggravates Gut Microbiota Dysbiosis and Liver Injury in Mice With Non-alcoholic Steatohepatitis. | 2021 | Details |
| A01304 | 34795391 | Commun Biol | Precancerous liver diseases do not cause increased mutagenesis in liver stem cells. | 2021 | Details |
| A01305 | 34795230 | Cell Death Dis | Molecular and histological traits of reduced lysosomal acid lipase activity in the fatty liver. | 2021 | Details |
| A01306 | 34794397 | BMC Endocr Disord | Gallstone disease and nonalcoholic fatty liver disease in patients with type 2 diabetes: a cross-sectional study. | 2021 | Details |
| A01307 | 34794237 | Biomed Pharmacother | Anti-inflammatory and anti-fibrotic effects of modafinil in nonalcoholic liver disease. | 2021 | Details |
| A01308 | 34794234 | Biomed Pharmacother | Saroglitazar and Hepano treatment offers protection against high fat high fructose diet induced obesity, insulin resistance and steatosis by modulating various class of hepatic and circulating lipids. | 2021 | Details |
| A01309 | 34794182 | Semin Liver Dis | The Neglected Role of Bile Duct Epithelial Cells in NASH. | 2021 | Details |
| A01310 | 34794021 | Ecotoxicol Environ Saf | Relationships among N,N-dimethylformamide exposure, CYP2E1 and TM6SF2 genes, and non-alcoholic fatty liver disease. | 2021 | Details |
| A01311 | 34793868 | J Hepatol | Non-invasive evaluation of response to obeticholic acid in patients with NASH: Results from the REGENERATE study. | 2021 | Details |
| A01312 | 34793866 | J Hepatol | A new perspective on NAFLD: Focusing on lipid droplets. | 2021 | Details |
| A01313 | 34791524 | Int J Colorectal Dis | Disease activity in inflammatory bowel disease patients is associated with increased liver fat content and liver fibrosis during follow-up. | 2021 | Details |
| A01314 | 34791370 | J Nutr | Dietary and Lifestyle Inflammation Scores Are Inversely Associated with Metabolic-Associated Fatty Liver Disease among Iranian Adults: A Nested Case-Control Study. | 2022 | Details |
| A01315 | 34790034 | Int J Med Sci | Radiomics based on fluoro-deoxyglucose positron emission tomography predicts liver fibrosis in biopsy-proven MAFLD: a pilot study. | 2021 | Details |
| A01316 | 34789275 | J Nanobiotechnology | A nanodrug system overexpressed circRNA_0001805 alleviates nonalcoholic fatty liver disease via miR-106a-5p/miR-320a and ABCA1/CPT1 axis. | 2021 | Details |
| A01317 | 34789244 | Lipids Health Dis | Protective effect of quercetin against the metabolic dysfunction of glucose and lipids and its associated learning and memory impairments in NAFLD rats. | 2021 | Details |
| A01318 | 34789138 | Curr Med Imaging | Evaluation of Aortic Distensibility in Patients with Nonalcoholic Fatty Liver using CT. | 2021 | Details |
| A01320 | 34788749 | Oncology | Dynamics of Circulating miR-122 Predict Liver Cancer and Mortality in Japanese Patients with Histopathologically Confirmed NAFLD and Severe Fibrosis Stage. | 2021 | Details |
| A01321 | 34788612 | Cell Rep | TM4SF5-dependent crosstalk between hepatocytes and macrophages to reprogram the inflammatory environment. | 2021 | Details |
| A01322 | 34787864 | Eur Rev Med Pharmacol Sci | The role of gluten-free diet in nonalcoholic fatty liver disease development. | 2021 | Details |
| A01323 | 34787756 | Biochem Genet | Identification of Key Pathways and Genes in SARS-CoV-2 Infecting Human Intestines by Bioinformatics Analysis. | 2021 | Details |
| A01324 | 34786857 | Mol Nutr Food Res | Oxidized Pork Induces Hepatic Steatosis by Impairing Thyroid Hormone Function in Mice. | 2021 | Details |
| A01325 | 34786828 | Kaohsiung J Med Sci | Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein expression predicts disease severity in nonalcoholic steatohepatitis patients. | 2021 | Details |
| A01326 | 34786549 | JHEP Rep | Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates. | 2021 | Details |
| A01327 | 34786546 | Chronic Dis Transl Med | Identification of key genes and pathways in mild and severe nonalcoholic fatty liver disease by integrative analysis. | 2021 | Details |
| A01328 | 34786524 | Hepatoma Res | The roles of autophagy and thyroid hormone in the pathogenesis and treatment of NAFLD. | 2021 | Details |
| A01329 | 34786236 | Cureus | Non-alcoholic Fatty Liver Disease and Carbohydrate Restricted Diets: A Case Report and Literature Review. | 2021 | Details |
| A01330 | 34786215 | IEEE J Transl Eng Health Med | Ultrasound Sample Entropy Imaging: A New Approach for Evaluating Hepatic Steatosis and Fibrosis. | 2021 | Details |
| A01331 | 34786176 | World J Hepatol | Machine learning models for predicting non-alcoholic fatty liver disease in the general United States population: NHANES database. | 2021 | Details |
| A01332 | 34786174 | World J Hepatol | Serum zonulin levels in patients with liver cirrhosis: Prognostic implications. | 2021 | Details |
| A01333 | 34786172 | World J Hepatol | Liver and COVID-19: From care of patients with liver diseases to liver injury. | 2021 | Details |
| A01334 | 34786161 | World J Hepatol | Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease. | 2021 | Details |
| A01335 | 34785918 | Diabetes Metab Syndr Obes | Association Between Aspartate Aminotransferase to Alanine Aminotransferase Ratio and Incidence of Type 2 Diabetes Mellitus in the Japanese Population: A Secondary Analysis of a Retrospective Cohort Study. | 2021 | Details |
| A01336 | 34785385 | Clin Res Hepatol Gastroenterol | Trans-anethole attenuates diet-induced nonalcoholic steatohepatitis through suppressing TGF-β-mediated fibrosis. | 2021 | Details |
| A01337 | 34784620 | Exp Clin Endocrinol Diabetes | Shear Wave Elastography Reveals a High Prevalence of NAFLD-related Fibrosis Even in Type 1 Diabetes. | 2021 | Details |
| A01338 | 34783592 | Radiology | Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease. | 2021 | Details |
| A01339 | 34783554 | J Agric Food Chem | Novel Sesquiterpene Glycoside from Loquat Leaf Alleviates Type 2 Diabetes Mellitus Combined with Nonalcoholic Fatty Liver Disease by Improving Insulin Resistance, Oxidative Stress, Inflammation, and Gut Microbiota Composition. | 2021 | Details |
| A01340 | 34783191 | Hepatol Commun | Predicting Liver-Related Outcomes in People With Nonalcoholic Fatty Liver Disease: The Prognostic Value of Noninvasive Fibrosis Tests. | 2021 | Details |
| A01341 | 34783091 | J Hum Nutr Diet | The Dietary Inflammatory Index and hepatic health in the US adult population. | 2021 | Details |
| A01342 | 34783017 | Br J Pharmacol | A novel HSF1 activator ameliorates non-alcoholic steatohepatitis by stimulating mitochondrial adaptive oxidation. | 2022 | Details |
| A01343 | 34781143 | Biomed Pharmacother | Carminic acid mitigates fructose-triggered hepatic steatosis by inhibition of oxidative stress and inflammatory reaction. | 2021 | Details |
| A01344 | 34780785 | Exp Cell Res | MicroRNA-22 inhibition promotes the development of atherosclerosis via targeting interferon regulator factor 5. | 2021 | Details |
| A01345 | 34780166 | Chem Res Toxicol | Differential Roles of Water-Insoluble and Water-Soluble Fractions of Diesel Exhaust Particles in the Development of Adverse Health Effects Due to Chronic Instillation of Diesel Exhaust Particles. | 2021 | Details |
| A01346 | 34780030 | Hepatol Int | Impact of non-alcoholic fatty liver disease on the risk of sarcopenia: a nationwide multicenter prospective study. | 2021 | Details |
| A01347 | 34779535 | Hepatology | Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease. | 2021 | Details |
| A01348 | 34779464 | Food Funct | MUFA in metabolic syndrome and associated risk factors: is MUFA the opposite side of the PUFA coin? | 2021 | Details |
| A01349 | 34779413 | J Clin Invest | Controversies surrounding peripheral cannabinoid receptor 1 in fatty liver disease. | 2021 | Details |
| A01350 | 34778544 | Transplant Direct | Utility of Metabolomic Biomarkers to Identify Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients. | 2021 | Details |
| A01351 | 34778314 | Front Med (Lausanne) | Longitudinal Associations Between Hand Grip Strength and Non-Alcoholic Fatty Liver Disease in Adults: A Prospective Cohort Study. | 2021 | Details |
| A01352 | 34778099 | Front Cell Infect Microbiol | Gut Microbiota, Glucose, Lipid, and Water-Electrolyte Metabolism in Children With Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01353 | 34777740 | Ther Adv Chronic Dis | The association between NAFLD and risk of chronic kidney disease: a cross-sectional study. | 2021 | Details |
| A01354 | 34777484 | Front Genet | Bioinformatics Analysis Explores Potential Hub Genes in Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01355 | 34777261 | Front Endocrinol (Lausanne) | Endotoxins and Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A01356 | 34777255 | Front Endocrinol (Lausanne) | Emerging Roles of T Cells in the Pathogenesis of Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma. | 2021 | Details |
| A01357 | 34776827 | Food Nutr Res | Weissella cibaria MG5285 and Lactobacillus reuteri MG5149 attenuated fat accumulation in adipose and hepatic steatosis in high-fat diet-induced C57BL/6J obese mice. | 2021 | Details |
| A01358 | 34775841 | Exp Biol Med (Maywood) | Bioinformatics analysis of an animal model of diet-induced nonalcoholic fatty liver disease with rapid progression. | 2021 | Details |
| A01359 | 34774989 | Cell Signal | LncRNA HOTAIR regulates the lipid accumulation in non-alcoholic fatty liver disease via miR-130b-3p/ROCK1 axis. | 2021 | Details |
| A01360 | 34774753 | Mol Ther | An RNAi therapeutic targeting hepatic DGAT2 in a genetically obese mouse model of nonalcoholic steatohepatitis. | 2021 | Details |
| A01362 | 34774623 | Life Sci | Hepatic cytochrome P450 function is reduced by life-long Western diet consumption in guinea pig independent of birth weight. | 2021 | Details |
| A01365 | 34774104 | Trials | Effects of naringenin supplementation in overweight/obese patients with non-alcoholic fatty liver disease: study protocol for a randomized double-blind clinical trial. | 2021 | Details |
| A01366 | 34773939 | Clin Exp Pediatr | Effects of probiotics combined with dietary and lifestyle modification on clinical, biochemical, and radiological parameters in obese children with NASH/NAFLD: a randomized clinical trial. | 2021 | Details |
| A01367 | 34773291 | Transpl Int | A meta-analysis on the prevalence of chronic kidney disease in liver transplant candidates and its associated risk factors and outcomes. | 2021 | Details |
| A01368 | 34773257 | Hepatology | A GLP-1/GLP-2 receptor dual agonist to treat NASH: Targeting the gut-liver axis and microbiome. | 2021 | Details |
| A01369 | 34773093 | Eur J Clin Nutr | Role of high-salt diet in non-alcoholic fatty liver disease: a mini-review of the evidence. | 2021 | Details |
| A01371 | 34772312 | J Int Med Res | Use of GP73 in the diagnosis of non-alcoholic steatohepatitis and the staging of hepatic fibrosis. | 2021 | Details |
| A01372 | 34771745 | Cancers (Basel) | In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling. | 2021 | Details |
| A01373 | 34771023 | Molecules | Zinc as a Drug for Wilson's Disease, Non-Alcoholic Liver Disease and COVID-19-Related Liver Injury. | 2021 | Details |
| A01374 | 34769488 | Int J Mol Sci | The Roles of Carbohydrate Response Element Binding Protein in the Relationship between Carbohydrate Intake and Diseases. | 2021 | Details |
| A01375 | 34769333 | Int J Mol Sci | Clinical and Molecular Biomarkers for Diagnosis and Staging of NAFLD. | 2021 | Details |
| A01376 | 34769332 | Int J Mol Sci | Association between Equol Production Status and Nonalcoholic Steatohepatitis. | 2021 | Details |
| A01377 | 34769060 | Int J Mol Sci | Pathophysiological Molecular Mechanisms of Obesity: A Link between MAFLD and NASH with Cardiovascular Diseases. | 2021 | Details |
| A01378 | 34768942 | Int J Mol Sci | In a Prediabetic Model, Empagliflozin Improves Hepatic Lipid Metabolism Independently of Obesity and before Onset of Hyperglycemia. | 2021 | Details |
| A01379 | 34768813 | Int J Mol Sci | The Ameliorative Effects of Saikosaponin in Thioacetamide-Induced Liver Injury and Non-Alcoholic Fatty Liver Disease in Mice. | 2021 | Details |
| A01380 | 34768539 | J Clin Med | What Do We Know about Inequalities in NAFLD Distribution and Outcomes? A Scoping Review. | 2021 | Details |
| A01381 | 34768440 | J Clin Med | Prothrombotic and Inflammatory Markers in Elderly Patients with Non-Alcoholic Hepatic Liver Disease before and after Weight Loss: A Pilot Study. | 2021 | Details |
| A01382 | 34768009 | Clin Gastroenterol Hepatol | Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global Non-Alcoholic Steatohepatitis (NASH)/ Non-Alcoholic Fatty Liver Disease (NAFLD) Registry. | 2021 | Details |
| A01383 | 34765514 | J Tradit Complement Med | Genistein and exercise treatment reduced NASH related HDAC3, IL-13 and MMP-12 expressions in ovariectomized rats fed with high fat high fructose diet. | 2021 | Details |
| A01384 | 34765249 | Curr Health Sci J | Contribution of Modern Echocardiographic Techniques in the Detection of Subclinical Heart Dysfunction in Young Adults with Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A01385 | 34765085 | Oxid Med Cell Longev | Target Sestrin2 to Rescue the Damaged Organ: Mechanistic Insight into Its Function. | 2021 | Details |
| A01386 | 34764881 | Front Physiol | Green Plant Pigment, Chlorophyllin, Ameliorates Non-alcoholic Fatty Liver Diseases (NAFLDs) Through Modulating Gut Microbiome in Mice. | 2021 | Details |
| A01387 | 34764398 | Sci Rep | A meta-analysis of the effects of glucagon-like-peptide 1 receptor agonist (GLP1-RA) in nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes (T2D). | 2021 | Details |
| A01388 | 34764005 | J Formos Med Assoc | Hepatic steatosis and development of type 2 diabetes: Impact of chronic hepatitis B and viral specific factors. | 2021 | Details |
| A01389 | 34763561 | J Int Med Res | Does the FT3-to-FT4 ratio easily predict the progression of NAFLD and NASH cirrhosis? | 2021 | Details |
| A01390 | 34763304 | Parkinsonism Relat Disord | Sex differences in the association between nonalcoholic fatty liver disease and Parkinson's disease. | 2021 | Details |